Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis

[1]  M. Emdin,et al.  Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis , 2019, Journal of Nuclear Cardiology.

[2]  R. Brunken,et al.  Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes , 2018, Journal of Nuclear Cardiology.

[3]  J. Dubois-Randé,et al.  Apical sparing pattern of left ventricular myocardial 99mTc-HMDP uptake in patients with transthyretin cardiac amyloidosis , 2018, Journal of Nuclear Cardiology.

[4]  J. Dubois-Randé,et al.  Early-phase myocardial uptake intensity of 99mTc-HMDP vs 99mTc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis , 2018, Journal of Nuclear Cardiology.

[5]  G. Antoni,et al.  Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR) , 2018, Journal of Nuclear Cardiology.

[6]  M. Hanna,et al.  Cardiac amyloidosis: An update on diagnosis and treatment , 2017, Cleveland Clinic Journal of Medicine.

[7]  A. Petrie,et al.  Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid , 2017, European heart journal cardiovascular Imaging.

[8]  M. Burrage,et al.  The Utility of 99mTc-DPD Scintigraphy in the Diagnosis of Cardiac Amyloidosis: An Australian Experience. , 2017, Heart, lung & circulation.

[9]  M. Leon,et al.  Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement , 2017, European heart journal.

[10]  S. Plein,et al.  Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography , 2017, European heart journal cardiovascular Imaging.

[11]  M. Cerqueira,et al.  Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality. , 2017, JACC. Cardiovascular imaging.

[12]  K. Shah,et al.  Transthyretin Cardiac Amyloidosis , 2017, Current Cardiology Reports.

[13]  P. Kellman,et al.  Magnetic Resonance in Transthyretin Cardiac Amyloidosis. , 2017, Journal of the American College of Cardiology.

[14]  C. Rapezzi,et al.  Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths , 2017, European heart journal.

[15]  G. Vorobiof,et al.  Cardiac Amyloidosis: Diagnosis and Treatment Strategies , 2017, Current Oncology Reports.

[16]  P. Elliott,et al.  Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis , 2017, Circulation.

[17]  H. Rousseau,et al.  Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[18]  G. Treglia,et al.  Systematic reviews and meta-analyses of diagnostic studies: a practical guideline , 2017, Clinical and Translational Imaging.

[19]  B. Bettencourt,et al.  Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis , 2016, Journal of Nuclear Cardiology.

[20]  J. Goldsmith,et al.  Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. , 2016, JAMA cardiology.

[21]  B. Khandheria,et al.  Quantitative Comparison Between Amyloid Deposition Detected by (99m)Tc-Diphosphonate Imaging and Myocardial Deformation Evaluated by Strain Echocardiography in Transthyretin-Related Cardiac Amyloidosis. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[22]  S. K. White,et al.  Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement. , 2016, Circulation. Cardiovascular imaging.

[23]  G. Dattilo,et al.  Left Atrial Morphology, Size and Function in Patients With Transthyretin Cardiac Amyloidosis and Primary Hypertrophic Cardiomyopathy　- Comparative Strain Imaging Study. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[24]  James C Moon,et al.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis , 2016, Circulation.

[25]  H. Rousseau,et al.  Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy , 2016, The International Journal of Cardiovascular Imaging.

[26]  J. Dubois-Randé,et al.  Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg? , 2016, European heart journal.

[27]  P. Westermark,et al.  99mTc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis , 2016, Upsala journal of medical sciences.

[28]  J. Dubois-Randé,et al.  Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis , 2015, Orphanet Journal of Rare Diseases.

[29]  A. Mazzeo,et al.  Usefulness of combining electrocardiogram and echocardiography findings and brain natriuretic peptide in early detection of cardiac amyloidosis in subjects with transthyretin gene mutation , 2015, Orphanet Journal of Rare Diseases.

[30]  S. Punwani,et al.  Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis , 2015, Journal of cardiovascular computed tomography.

[31]  E. González-López,et al.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. , 2015, European heart journal.

[32]  M. Dimopoulos,et al.  Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy. , 2015, Hellenic journal of nuclear medicine.

[33]  P. Hawkins,et al.  Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis. , 2014, European heart journal cardiovascular Imaging.

[34]  U. Haberkorn,et al.  Noninvasive risk stratification of patients with transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.

[35]  B. Hazenberg,et al.  Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis , 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[36]  S. K. White,et al.  Native T1 mapping in transthyretin amyloidosis. , 2014, JACC. Cardiovascular imaging.

[37]  M. Maurer,et al.  99mTc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses , 2013, Circulation. Cardiovascular imaging.

[38]  A. Mazzeo,et al.  Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy. , 2013, AJR. American journal of roentgenology.

[39]  G. Vita,et al.  Transthyretin‐related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset , 2012, Journal of the peripheral nervous system : JPNS.

[40]  P. García-Pavía,et al.  Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype. , 2012, Revista espanola de cardiologia.

[41]  P. García-Pavía,et al.  Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype. , 2012, Revista espanola de cardiologia.

[42]  F. Salvi,et al.  Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. , 2011, JACC. Cardiovascular imaging.

[43]  F. Salvi,et al.  Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[44]  C. Anfuso,et al.  MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy. , 2010, AJR. American journal of roentgenology.

[45]  W. Aronow,et al.  Cardiac Amyloidosis: Approaches to Diagnosis and Management , 2010, Cardiology in review.

[46]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.

[47]  S. Neubauer,et al.  Evaluation and management of the cardiac amyloidosis. , 2007, Journal of the American College of Cardiology.

[48]  F. Salvi,et al.  Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. , 2005, Journal of the American College of Cardiology.

[49]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[50]  R. Linke,et al.  99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[51]  F. Ruberg,et al.  Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment. , 2018, Trends in cardiovascular medicine.

[52]  Zhezhen Jin,et al.  Erratum to: Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis , 2016, Journal of Nuclear Cardiology.

[53]  I. Cho,et al.  Clinical issues regarding misclassification by Dixon based PET/MR attenuation correction. , 2015, Hellenic journal of nuclear medicine.

[54]  I. Kayani,et al.  Myocardial uptake of 99mTc-HDP and reduced perfusion on CT in subacute myocardial infarction. , 2014, Clinical nuclear medicine.

[55]  U. Guerra,et al.  Extraosseous myocardial uptake incidentally detected during bone scan: report of three cases and a systematic literature review of extraosseous uptake. , 2013, Nuclear medicine review. Central & Eastern Europe.